E2F8-CENPL pathway contributes to homologous recombination repair and chemoresistance in breast cancer
Cellular Signalling · 2024
DOI: 10.1016/j.cellsig.2024.111151 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cellular Signalling, 2024. Verfasst von Shan Wang und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathophysiology, College of Basic Medical Science, China Medical University, Shenyang 110122, Liaoning Province, PR China. Hauptthemen laut MEDLINE: Recombinational DNA Repair, Breast Neoplasms. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 33 Literaturangaben. Gefördert von: Scientific Research Fund of Liaoning Provincial Education Department, Department of Education of Liaoning Province, National Natural Science Foundation of China.
Abstract (Originalsprache)
Chemoresistance poses a significant obstacle to the treatment of breast cancer patients. The increased capacity of DNA damage repair is one of the mechanisms underlying chemoresistance. Bioinformatic analyses showed that E2F8 was associated with cell cycle progression and homologous recombination (HR) repair of DNA double-strand breaks (DSBs) in breast cancer. E2F8 knockdown suppressed cell growth and attenuated HR repair. Accordingly, E2F8 knockdown sensitized cancer cells to Adriamycin and Cisplatin. Centromere protein L (CENPL) is a transcriptional target by E2F8. CENPL overexpression in E2F8-knockdowned cells recovered at least in part the effect of E2F8 on DNA damage repair and chemotherapy sensitivity. Consistently, CENPL knockdown impaired DNA damage repair and sensitized cancer cells to DNA-damaging drugs. These findings demonstrate that targeting E2F8-CENPL pathway is a potential approach to overcoming chemoresistance.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pathophysiology, College of Basic Medical Science, China Medical University, Shenyang 110122, Liaoning Province, PR China.
- Department of Intelligent Computation, School of Intelligent Medicine, China Medical University, Shenyang 110122, Liaoning Province, PR China. Electronic address: lfshan@cmu.edu.cn.
- Department of Pancreatic and Biliary Surgery, The First Hospital of China Medical University, Shenyang 110001, Liaoning Province, PR China. Electronic address: zbzhang@cmu.edu.cn.
- Department of Pathophysiology, College of Basic Medical Science, China Medical University, Shenyang 110122, Liaoning Province, PR China. Electronic address: chzhao@cmu.edu.cn.
Förderung
- Scientific Research Fund of Liaoning Provincial Education Department
- Department of Education of Liaoning Province
- National Natural Science Foundation of China
Zitieren
APA
Wang, S., Xia, Y., Sun, Y., Wang, W., Shan, L., Zhang, Z., & Zhao, C. (2024). E2F8-CENPL pathway contributes to homologous recombination repair and chemoresistance in breast cancer. Cellular Signalling. https://doi.org/10.1016/j.cellsig.2024.111151
Vancouver
Wang S, Xia Y, Sun Y, Wang W, Shan L, Zhang Z, et al. E2F8-CENPL pathway contributes to homologous recombination repair and chemoresistance in breast cancer. Cellular Signalling. 2024. doi:10.1016/j.cellsig.2024.111151
BibTeX
@article{Wang2024,
author = {Wang, Shan and Xia, Yuhong and Sun, Yu and Wang, Wei and Shan, Lianfeng and Zhang, Zhongbo and Zhao, Chenghai},
title = {E2F8-CENPL pathway contributes to homologous recombination repair and chemoresistance in breast cancer},
journal = {Cellular Signalling},
year = {2024},
doi = {10.1016/j.cellsig.2024.111151}
}
EUVIMED